Medical professionals sometimes diverge from local guidelines when treating transgender young people because they prioritise internationally recognised standards of care over more restrictive regional protocols. Research shows that different healthcare systems worldwide have varying approaches to gender-affirming care, with some countries adopting more conservative age-based restrictions while others follow evidence-based international guidelines.
The informed consent model, widely used internationally, emphasises individualised patient assessment rather than rigid age barriers. Evidence indicates that delaying appropriate treatment can lead to significant psychological distress when young people are forced to experience puberty that doesn't align with their gender identity. Studies demonstrate that timely access to gender-affirming care, including puberty blockers and hormone therapy when clinically appropriate, can substantially reduce mental health risks including depression, anxiety, and suicidal ideation.
Guidelines from major international medical organisations, including the World Professional Association for Transgender Health, emphasise the importance of individualised care based on thorough assessment rather than blanket age restrictions. Some healthcare providers believe that strictly adhering to conservative local protocols may compromise patient welfare when international evidence supports earlier intervention.
Healthcare decisions in this area remain complex, involving careful consideration of physical and psychological factors, family dynamics, and long-term outcomes. Medical professionals who diverge from local guidelines typically do so after thorough assessment, believing that evidence-based international standards better serve their patients' immediate and long-term wellbeing.